CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 4 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,728,876 | -13.9% | 318,980 | -1.0% | 0.08% | -10.1% |
| Q2 2023 | $4,332,438 | -18.0% | 322,354 | +1.1% | 0.09% | -17.6% |
| Q1 2023 | $5,284,842 | -10.6% | 318,748 | +0.3% | 0.11% | -11.5% |
| Q4 2022 | $5,911,880 | +83.4% | 317,843 | +26.5% | 0.12% | +79.4% |
| Q3 2022 | $3,223,000 | +85.0% | 251,193 | +1.1% | 0.07% | +106.1% |
| Q2 2022 | $1,742,000 | +56.0% | 248,522 | +84.4% | 0.03% | +94.1% |
| Q1 2022 | $1,117,000 | +274.8% | 134,779 | +206.6% | 0.02% | +325.0% |
| Q4 2021 | $298,000 | – | 43,959 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |